News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
1420
Sources here
15
Companies here
25
Search results Stored financial headlines

Active search

1420 matching headlines

Ticker or company: ESIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cartesian Therapeutics (NASDAQ:RNAC) Announces Quarterly Earnings Results

Cartesian Therapeutics (NASDAQ:RNAC) announced its quarterly earnings, reporting an EPS of $0.46, significantly beating the consensus estimate of a $0.88 loss. Following the announcement, RNAC shares rose 1.0% to $8.85, with analysts maintaining a "Moderate Buy" rating and an average price target of $32.60. …

RNAC main company
Sharemaestro market context Trend signal active 52 weeks -21.3% RNAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Designer Brands Inc - Ordinary Shares - Class A (DBI) News, Articles, Events & Latest Updates

This page provides news and updates related to Designer Brands Inc (DBI). It features various articles discussing Q2 earnings and outlooks for several retail and fashion companies like Dillard's, Revolve Group, Arhaus, Somnigroup, Victoria's Secret, Sally Beauty, and Steven Madden. The content also includes …

DBI main company
Sharemaestro market context Price below Trend Line 52 weeks +70.0% DBI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cadence Design Systems, Inc. $CDNS Position Trimmed by Seilern Investment Management Ltd

Seilern Investment Management Ltd. reduced its stake in Cadence Design Systems (CDNS) by 21.5% in the second quarter, selling 31,351 shares but still holding 114,321 shares valued at $42.9 million. Despite this trimming and significant insider selling, analyst sentiment remains positive with a "Moderate …

CDNS main company
Sharemaestro market context Trend signal active 52 weeks -7.1% CDNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resideo Technologies, Inc. $REZI Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP significantly increased its stake in Resideo Technologies, Inc. (NYSE:REZI) during the first quarter, now holding 98,948 shares valued at $3.34 million. Despite mixed analyst ratings leading to a "Hold" consensus, Resideo's recent quarterly earnings surpassed expectations, and the company provided …

REZI main company
Sharemaestro market context Price below Trend Line 52 weeks -13.4% REZI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Genesis Energy (GEL) Stock Eyes Debt Reset After Return To Profit

Genesis Energy (GEL) has returned to profit in Q2 2026, reporting US$0.35 EPS and US$42.9m net income, a significant turnaround from previous losses. The company's management is actively restructuring its balance sheet by retiring high-cost preferreds and refinancing debt, aiming for future interest savings. …

GNE main company GEL main company
Sharemaestro market context Trend signal active 52 weeks +9.2% GNE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

(ARR) Price Dynamics and Execution-Aware Positioning

This article analyzes Armour Residential Reit Inc. (NYSE: ARR) stock dynamics, identifying strong near-term sentiment leading to a long-term positive bias. It highlights a significant 23.2:1 risk-reward setup targeting a 7.1% gain versus 0.3% risk. The report also outlines three AI-generated trading strategies—Position Trading, …

ARR main company
Sharemaestro market context Price above Trend Line 52 weeks +26.9% ARR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Quick Look at Today's Ratings for Cartesian Therapeutics(RNAC.US), With a Forecast Between $25 to $44

This article provides an overview of recent analyst ratings for Cartesian Therapeutics (RNAC.US), highlighting a price target forecast ranging from $25 to $44. It indicates that the company has received a "Strong Buy" consensus from analysts, based on positive evaluations over the past three …

RNAC main company
Sharemaestro market context Trend signal active 52 weeks -21.3% RNAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cadence Design Systems (CDNS) Could Be 14% Undervalued Following Raised 2026 Outlook

Cadence Design Systems (CDNS) reported strong Q2 2026 results with increased revenue and net income, leading to a raised full-year outlook. Despite short-term share price fluctuations, the company's long-term returns have been substantial. Simply Wall St's analysis suggests CDNS is 14.3% undervalued, yet its …

CDNS main company CDNS main company
Sharemaestro market context Trend signal active 52 weeks -14.3% CDNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cartesian Therapeutics (NASDAQ:RNAC) Upgraded by Wall Street Zen to Hold Rating

Cartesian Therapeutics (NASDAQ:RNAC) was upgraded by Wall Street Zen from a "sell" to a "hold" rating. Despite this upgrade, the company still holds a "Moderate Buy" consensus rating among analysts with an average price target of $32.60. Institutional investors own a significant portion of …

RNAC main company
Sharemaestro market context Trend signal active 52 weeks -21.3% RNAC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Genesis Energy Q2 Earnings Call Highlights

Genesis Energy's Q2 2026 performance met internal expectations, with a focus on strengthening its capital structure through asset sales and preferred security retirements. The company increased its quarterly distribution and outlined future annual cash savings. While the Offshore Pipeline Transportation segment faced temporary challenges, …

GEL main company
Sharemaestro market context Price below Trend Line 52 weeks -4.6% · Next-week setup positive 61.1% GEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Update: Here's Why Analysts Just Lifted Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$32.67

Biodesix, Inc. (NASDAQ:BDSX) recently released its quarterly results, showing better-than-expected revenues of US$27m and smaller statutory losses of US$0.71 per share. Following these results, analysts have updated their forecasts for 2026, predicting revenues of US$111.5m and reduced losses per share. This positive outlook has …

BDSX main company
Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8% BDSX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Genesis Energy (GEL) Could Be 70% Undervalued As Earnings Return To Profit

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Genesis Energy (GEL) has drawn fresh attention after reporting second quarter 2026 earnings, with …

GEL main company
Sharemaestro market context Price below Trend Line 52 weeks -4.6% · Next-week setup positive 61.1% GEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Uni-President China Holdings (SEHK:220) After Earnings Growth, Is The Valuation Too Rich?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Uni-President China Holdings Stock Is Back in Focus After Earnings Uni-President China Holdings (SEHK:220) is back on investor radar after reporting its half …

0220 main company
Sharemaestro market context Price above Trend Line 52 weeks -17.6% 0220 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amesite Inc (AMST) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Amesite Inc (AMST), detailing its current stock price, market capitalization, and a brief overview of its financial data and technical analysis. It also lists top peer companies with their analyst ratings for comparison. The information is updated …

AMST main company
Sharemaestro market context Price below Trend Line 52 weeks -63.9% AMST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Resideo Technologies (NYSE:REZI) Reaches New 12-Month Low - Time to Sell?

Resideo Technologies (NYSE:REZI) recently hit a new 52-week low of $25.46, trading well below its 50-day and 200-day moving averages. Analyst sentiment is mixed but cautious, with a consensus "Hold" rating and a $41 price target, despite recent ratings ranging from "strong sell" to …

REZI main company
Sharemaestro market context Price below Trend Line 52 weeks -13.4% REZI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

J.P. Morgan Initiates Resideo Technologies(REZI.US) With Hold Rating, Announces Target Price $30

J.P. Morgan has initiated coverage on Resideo Technologies (REZI.US) with a Hold rating. The firm has set a target price of $30 for the company's stock.

REZI main company
Sharemaestro market context Price below Trend Line 52 weeks -13.4% REZI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Empowered Funds LLC Invests $1.71 Million in Element Solutions Inc. $ESI

Empowered Funds LLC has acquired a new stake of 50,033 shares in Element Solutions Inc. (NYSE:ESI), valued at approximately $1.71 million, according to its latest SEC filing. This makes them one of many institutional investors, who collectively own 92.32% of the company, to recently …

ESI main company
Sharemaestro market context Trend signal active 52 weeks +51.4% ESI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Equity Residential $EQR Shares Sold by Aurora Investment Managers LLC.

Aurora Investment Managers LLC significantly reduced its stake in Equity Residential (NYSE:EQR) by 81.4% in the second quarter, selling 46,048 shares and retaining 10,550 shares valued at $717,000. Despite this sell-off, institutional investors collectively own 92.68% of the REIT, and analysts maintain a consensus …

EQR main company
Sharemaestro market context Trend signal active 52 weeks +4.6% EQR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context